News | News By Subject | News by Disease News By Date | Search News

Herpes simplex virus News Articles

Get Our FREE
Industry eNewsletter
Top Breaking News
Big-Name Investor Peter Thiel Funds ‘Unethical’ Offshore Herpes Vaccine Trial     8/28/2017
Three Cancer Drugs are Up for FDA Approval in October     9/28/2015
AmerisourceBergen Corporation (ABC) the “Pony to Ride” for Biosimilar Opportunities, Says UBS     3/16/2015
Analyst: Current Crop of Biotech IPOs a Mixed Bag of Low Market Caps, Little Data     12/3/2014
Best Value In Biotech? Actavis (ACT), Says UBS     11/17/2014
Massachusetts' Agenus (AGEN) Touts Positive Phase 2 Data From HerpV Study     6/26/2014
Genocea Biosciences's Herpes Simplex Virus Vaccine Heads for Critical Proving Ground     9/13/2013
Clinigen Gains FDA Approval for Foscavir in HIV/AIDS-related Cytomegalovirus Infections and Herpes     5/8/2012
GlaxoSmithKline (GSK) Enters Agreement with Medivir AB (MVIRb.F) for Exclusive Rights to Cold Sore Treatment Xerclear; GSK to Pay up to Euro 3 Million Up-front and up to Double-Digit Royalties on Sales to Medivir     6/23/2010
MediGene AG (DX:MDG) Divests Oncolytic Herpes Simplex Viruses (oHSV) Program to Catherex, Inc.; MediGene to Receive a 40% Stake in Catherex     4/13/2010
Vical Incorporated (VICL) Gets US Patent for Herpes DNA Vaccine     12/22/2009
ViroPharma Incorporated (VPHM) Wins Orphan Drug Status For Maribavir     2/7/2007
Quigley Corporation (QGLY) Herpes Treatment QR-435 Fails In Animal Testing     12/28/2006
Sciele Pharma, Inc. (SCRX) Signs Exclusive Zovirax(R) Promotional Agreement With Biovail Corporation (BVF)     12/20/2006
Barrier Therapeutics, Inc. (BTRX) Acquires Canadian Distribution Rights For Denavir(R)     3/15/2006

News from Around the Web
Thiel-Backed Biotech Rational Vaccines Will Follow FDA Guidelines After Offshore Trial Controversy     9/5/2017
Your Viruses Could Reveal Your Background, Lancaster University Study     4/11/2016
How Stress Wakes Up The Sleeping Herpes Virus, University of Helsinki Study     2/25/2016
How Herpes Simplex Virus Reactivates In Neurons To Trigger Disease, University of North Carolina Reveals     12/16/2015
Researchers Link Herpes to Alzheimer's Disease; "Cold Sores" Connected to Cognitive Decline, University of New Mexico and Collaborators Find     4/5/2011
Study Links Severe Drug Reaction to Herpes Virus, National Institute for Health and Medical Research (INSERM) Study     8/26/2010
Herpes Virus Treats Head And Neck Cancer Patients, The Institute of Cancer Research Study     8/2/2010
Microbicide Also Protects Against Herpes, Centre for the AIDS Program of Research in South Africa (CAPRISA) Researcher Says     7/21/2010
Circumcision Cuts Rates of Herpes, HPV, Johns Hopkins University And Study     3/26/2009
Herpes Drug Inhibits HIV Replication, But With A Price, Johns Hopkins University Study     11/7/2008
"Sumo Virus" Warning Is Issued; Deadly Rugby Virus Spreads In Sumo Wrestlers -- National Institute of Infectious Diseases in Tokyo, Japan     9/29/2008
Herpes Virus Changes Anti-Herpes Drug to Form that Hinders AIDS Virus, National Institutes of Health (NIH) Study     9/11/2008
Duke University Discover New Hope Against the Cold Sore Virus     7/3/2008
Second Study Finds Treating Herpes Won't Stop HIV, London School of Hygiene and Tropical Medicine Study     3/13/2008
Novel Vaccine Concept Developed By Scientists At The Wistar Institute     1/31/2008

Press Releases
Vical  (VICL) Completes Target Enrollment In Its Phase II Therapeutic HSV-2 Vaccine Trial     4/19/2017
Flawed Herpes Testing Leads To Many False Positives — And Needless Suffering     1/26/2017
Slayback Pharma Announces The Final Approval And Launch Of Generic Zovirax (Acyclovir) Ointment 5%     12/27/2016
SpeeDx Receives CE-IVD Mark for PlexPCR HSV-1&2, VZV Kit     6/29/2016
NanoViricides, Inc. (NNVC.PK) Reports On Progress Of Its Drug Candidates Against Herpesviruses     6/20/2016
Envigo Rat Models Proven To Be Susceptible To Intra-Vaginal HSV-2 Infection And Protectable By Attenuated HSV-1 Against Symptomatic HSV-2     2/1/2016
Genticel To Evaluate Roche Molecular Systems (RHHBF.PK)’ cobas HPV Test In Preparation For PhIII Program Of GTL001     1/7/2016
ContraVir To Present At Biotech Showcase 2016     1/5/2016
Chimerix (CMRX) And BARDA Announce Contract Extension Of $13.0 Million For The Continued Development Of Brincidofovir For Smallpox     9/14/2015
Focus Diagnostics, Inc. Receives FDA Clearance To Add Genital Swab Claim To Moderate Complexity Simplexa HSV 1 & 2 Direct Molecular Test     9/3/2015
ContraVir Pharmaceuticals To Present At Rodman & Renshaw 17th Annual Global Investment Conference     9/2/2015
NanoViricides, Inc. (NNVC.PK) Reports That The Dramatic Effects Of Its Topical Anti-Herpes Treatment Were Reproduced Once Again In An Animal Model In A Different Laboratory     8/10/2015
Vical Incorporated (VICL) Completes Enrollment In Its Therapeutic HSV-2 Vaccine Clinical Trial     12/11/2014
Sanofi Pasteur (SASY.PA) And Immune Design Corporation (IMDZ) Enter Broad Collaboration For The Development Of A Herpes Simplex Virus Therapy     10/16/2014
Vical Incorporated (VICL) Granted Six U.S. Patents For HSV-2 Vaccines     10/8/2014